Blood Clot Retrieval Devices Market
                     Blood Clot Retrieval Devices Market to 
Reach $10.9 Billion by 2036
Market to grow at 15% CAGR; cerebral arteries to hold 47.7% share; China to lead 
growth at 20.3%.
August 28, 2026 — The blood clot retrieval devices market is projected to grow from USD 2.8 billion in 
2026 to USD 10.9 billion by 2036 at a CAGR of 15%, according to Fact.MR. The market was valued 
at USD 2.4 billion in 2025, while the absolute dollar growth from 2026 to 2036 is projected at USD 8.1 
billion.
Stroke Management Drives Demand for Clot Retrieval Devices
Blood clot retrieval devices are used to remove thrombi from blood vessels and restore blood flow. The 
products include mechanical thrombectomy systems and aspiration catheters. They are used in conditions 
such as acute ischemic stroke and deep vein thrombosis.
Demand is rising as healthcare providers focus on faster stroke treatment and minimally invasive 
procedures. The growing prevalence of cardiovascular diseases and greater awareness of stroke 
management are also supporting adoption. Technological advances are improving the efficacy, precision, 
and ease of use of thrombectomy devices.
However, high procedure costs and limited access to advanced healthcare in some regions may restrict 
market expansion. Device manufacturers must balance product innovation with affordability while meeting 
regulatory and clinical requirements.
Get detailed market forecasts, competitive benchmarking, and pricing 
trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=14472
Dated Industry Proof Points       
The supplied Fact.MR page identifies several dated developments that support the changing treatment 
environment. In February 2026, the American Stroke Association released updated acute ischemic stroke 
guidelines that endorsed tenecteplase alongside traditional alteplase and provided structured 
recommendations for pediatric mechanical thrombectomy. Also in February 2026, Avantec Vascular, a 
Nipro company, received FDA 510(k) clearance for a DVT thrombectomy system. A multi-
society AHA/ACC/CHEST report published in February 2026 introduced a new classification for acute 
pulmonary embolism and identified mechanical thrombectomy as a reasonable first-line advanced therapy 
for certain high-risk patients. The supplied page does not provide additional dated third-party numerical 
statistics, so none have been added.
Key Numbers
Metric Fact.MR Data
Market Value, 2025 USD 2.4 billion
Market Size, 2026 USD 2.8 billion
Market Forecast, 2036 USD 10.9 billion
CAGR, 2026–2036 15%
Absolute Dollar Growth, 2026–2036 USD 8.1 billion
Cerebral Arteries Share, 2026 47.7%
Ischemic Stroke Share, 2026 39.6%
Source: Fact.MR analysis.
Segment Analysis
Cerebral arteries lead by application. Cerebral arteries are projected to account for 47.7% of the 
market in 2026. Devices used in these arteries are critical for treating ischemic strokes caused by 
blockages in the brain. Timely treatment helps restore blood flow and reduce the risk of severe outcomes.
Ischemic stroke remains a major stroke-type segment. Ischemic stroke is expected to capture 39.6%
share in 2026. These strokes occur when a blood clot blocks a blood vessel in the brain. Blood clot retrieval
devices can quickly remove the clot and restore circulation.
Stent retrievers support thrombectomy adoption. Stent retrievers are widely used during 
thrombectomy procedures because of their effectiveness in clot removal. Continued advances in 
neurovascular intervention are supporting demand for more precise and efficient devices.
Country Growth Outlook
Country CAGR 2026–2036
China 20.3%
India 18.8%
Germany 17.3%
France 15.8%
United Kingdom 14.3%
Source: Fact.MR analysis based on its proprietary forecasting model and primary research.
China leads country growth at 20.3% CAGR. Rising healthcare infrastructure, stroke incidence, and 
adoption of advanced medical technologies are supporting demand.
India follows at 18.8% CAGR. Increasing healthcare access, stroke awareness, and demand for advanced
treatments are expected to support market growth.
Germany is projected to grow at 17.3% CAGR. Strong healthcare infrastructure and adoption of 
advanced medical devices support demand. France and the United Kingdom are forecast to grow 
at 15.8% and 14.3% CAGR, respectively.
Competitive Landscape
Competition in the blood clot retrieval devices market centers on product efficacy, clinical outcomes, 
technology, regulatory expertise, and portfolio breadth. The supplied Fact.MR page 
identifies AngioDynamics, Inc., Terumo Corporation, Johnson & Johnson, ECKOS Corporation, 
Bayer HealthCare LLC, Boston Scientific Corporation, Argon Medical Devices, Inc., Medtronic plc, 
Teleflex Incorporated, and Penumbra, Inc. as key players.
Large healthcare providers and group purchasing organizations can influence supplier selection through 
quality and performance requirements. Buyers may qualify multiple suppliers and negotiate long-term 
contracts. Companies with strong R&D capabilities, advanced technologies, and regulatory expertise are 
positioned to compete for demand.
No individual company market-share percentages are provided in the supplied content. 
Therefore, no company shares have been assigned.
Analyst View
Shambhu Nath Jha, Principal Consultant at Fact.MR, stated: “The growing focus on stroke management
and the increasing adoption of mechanical thrombectomy is expected to continue driving the 
demand for blood clot retrieval devices globally.”
Frequently Asked Questions
1. What is the blood clot retrieval devices market size in 2026?
Fact.MR estimates the market at USD 2.8 billion in 2026.
2. How big will the blood clot retrieval devices market be in 2036?
The market is projected to reach USD 10.9 billion by 2036.
3. What is the CAGR of the blood clot retrieval devices market?
The market is forecast to grow at a 15% CAGR from 2026 to 2036.
4. Which application dominates the blood clot retrieval devices market?
Cerebral arteries are projected to account for 47.7% share in 2026.
5. Which country has the fastest projected growth?
China leads the listed countries with a projected 20.3% CAGR from 2026 to 2036.
Top Reports:
https://social.mytamam.com/blogs/34788/Adiponitrile-Market-to-Reach-24-5-Billion-by-2036
https://zeuspage.org/blogs/45466/Adiponitrile-Market-Set-to-Hit-24-5-Billion-by-2036
https://kaamkaaziclub.com/read-blog/43125
https://net-pals.com/blogs/26595/Adiponitrile-Market-Projected-to-Reach-24-5-Billion-by-2036
About Fact.MR
Fact.MR is a market research and consulting firm providing market intelligence, forecasts, competitive 
analysis, and strategic insights across global industries.